Aesthetic Medical SMR Eyes on Collagen Market

Abstract: Professional aesthetic medical repair brand SMR launched new products such as recombinant human-derived collagen lyophilized powder, claiming to apply recombinant Human-Like Collagen III independently developed by Taiyuan Biology. The recombinant Human-Like Collagen III has the characteristics of no virus hidden and low immunogenicity.

---

Collagen is an important part of the human body. As we all know, the main cause of skin aging is the loss of collagen. Due to its excellent physical and chemical properties, collagen has the ability to moisturize and nourish, tighten and smooth wrinkles, and repair skin tissues. It is popular in the field of repairing skin after aesthetic medicine, especially in the scenes of dressings, artificial organs and regenerative medicine, beauty, and cosmetics.

According to CHAILEEDO, China's collagen market is growing steadily and is the main driver in the aesthetic medical care sector. According to GrandViewResearch report, the market size of collagen in China grows to 983 million in 2019, accounting for about 6.40% of the global market. And by 2027, the market size of collagen in China is expected to reach 1.576 billion, accounting for approximately 6.96% of the global market.

In the Chinese market, the collagen giant Xi'an Giant Biogene is planning to go public. Its skincare brand Collgene, among others, is also making good gains. According to Frost & Sullivan, Giant Biogene is the second largest professional skincare products company (by retail sales) in China in 2021. It has been the largest collagen professional skincare products company (by retail sales) in China for three consecutive years from 2019 and is the first company in the world to achieve mass production of recombinant collagen skincare products. From 2019 to 2021, the group's other brand Kefumei achieved revenue of 290 million, $421 million and $898 million, accounting for 30.3%, 35.4% and 57.8% of total revenue, respectively. and Collgene revenue is $481 million, $559 million and $526 million, accounting for 50.3%, 47.0% and 33.9% of total revenue, respectively.

Many major international brands have also launched products about collagen, such as L'Oreal Paris, which has launched Age Perfect Collagen Expert Night Moisturizer, claiming to provide a daily boost of Collagen Peptides + Niacinamide to intensely rehydrate and firm maturing skin. The product is available for $14.8 in Tmall Global. Etude House has also launched collagen-related skincare products, but there is no official channel for them to be sold on Chinese e-commerce platforms. From this point, the international brand has not put more collagen-related products in China.

It is understood that SMR was established in 2013, and is a professional engaged in biomedical beauty, health industry and biomedical research and development, production, sales, training and service as one of the comprehensive high-tech enterprises. And SMR has cooperated Biopharmaceutical Research&Development Center of JiNan University, School of Biological Sciences and Engineering from South China University of Technology to form the brand strategy of "industry, academia, research and medical".

This time, SMR released a new product of recombinant Human-Like Collagen III and further reiterated the brand "7 days golden repair plan 0347 repair law". The new positioning is "professional medical repair, make beauty more beautiful", repositioning the aesthetic medical market. SMR stated that the launch of the recombinant Human-Like Collagen III is 100% homologous to humans and effectively circumvents the viral pitfalls and rejection reactions of traditional animal-derived collagen. It is generally higher than collagen on the market in terms of safety and effectiveness."

It is reported that SMR launched collagen lyophilized powder, collagen dressing and other medical device products, which are expected to be launched in July. According to the introduction, such products are used during and after surgery of aesthetic medicine respectively providing consumers with more options for repair after aesthetic medicine. This time, SMR launched high-quality recombinant Human-Like Collagen III products aiming to build a professional medical post-operative repair brand and help aesthetic medical consumers achieve the goal of making themselves more beautiful.